ALIPHATIC PROPARGYLAMINES AS CELLULAR RESCUE AGENTS
申请人:University of Saskatchewan Technologies Inc.
公开号:EP0996612B1
公开(公告)日:2003-04-09
EP1686973A4
申请人:——
公开号:EP1686973A4
公开(公告)日:2009-03-25
COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIOVASCULAR DISORDERS AND DISEASES
申请人:TECHNION RESEARCH AND DEVELOPMENT FOUNDATION, LTD.
公开号:EP1686973A1
公开(公告)日:2006-08-09
EXTENDED RELEASE FORMULATIONS OF RASAGILINE AND USES THEREOF
申请人:Pharma Two B Ltd.
公开号:EP2531181A1
公开(公告)日:2012-12-12
Methods for treatment of cardiovascular disorders and diseases
申请人:Youdim B.H. Moussa
公开号:US20060287401A1
公开(公告)日:2006-12-21
Propargylamine, propargylamine derivatives including N-propargyl-1-aminoindan, enantiomers and analogs thereof, and pharmaceutically acceptable salts thereof, are useful for prevention or treatment of cardiovascular disorders, diseases and conditions.